Development of a validated model allowing strategic positioning of early-stage therapies in the pharmaceutical market

The proposed project consists of developing a validated Excel model allowing strategic positioning of early-stage therapies in the pharmaceutical market according to their attractiveness. This model can be used by investors or researchers and will allow them to see how their drug compares to other molecules already marketed, having failed, or in development, in a specific indication. Ultimately, this model will guide investors and researchers in making decisions based on the potential attractiveness of the molecule in the selected market. Results of the project will be used internally by AmorChem Financial Inc. to analyze future investment opportunities, but the strategic positioning model can be also used by different investors, researchers, and consultants interested in market access analysis.

Faculty Supervisor:

Michelle Savoie

Student:

Partner:

AmorChem Financial Inc

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

Université de Montréal

Program: